Dr. David Abramson, MD, is a distinguished Ocular Oncology Specialist based in New York, NY, with an impressive 56 years of dedicated experience in the field. A graduate of the esteemed Albert Einstein College of Medicine, Dr. Abramson holds board certification in Ophthalmology, underscoring his extensive expertise and commitment to his specialty. He is currently affiliated with Memorial Sloan Kettering Cancer Center, where he provides top-notch care to his patients, earning a stellar average rating of 5.0 stars from those he serves.

With a focus on treating complex conditions such as Malignant Neoplasm of the Eye and Retinoblastoma, Dr. Abramson approaches each case with a deep commitment to patient-centered care. His long-standing experience and specialized knowledge enable him to effectively address the unique challenges presented by ocular cancers. By staying at the forefront of advancements in ocular oncology, Dr. Abramson ensures that his patients receive the most effective and innovative treatments available, fostering improved outcomes and enhanced quality of life.

Dr. Abramson’s dedication to his patients is reflected in his welcoming approach to new patients and his collaboration with a wide range of insurance providers, including Cigna, Blue Cross Blue Shield, and Aetna, among others. His commitment extends beyond individual patient care to include a broader engagement with the community, as he continually seeks to improve accessibility and outcomes for those affected by ocular conditions. His affiliation with a leading cancer center like Memorial Sloan Kettering further amplifies his impact, allowing him to integrate cutting-edge research with compassionate care.